India’s healthcare sector is no longer just a defensive bet in a volatile market, but one of the most compelling growth opportunities in the Indian financial market. India’s healthcare sector is expected to reach USD 700 billion by 2030, driven by the increasing health insurance penetration, an ageing population, a rise in chronic diseases, and a growing number of government initiatives for healthcare infrastructure.
The Union Budget 2026-27 raised its allocation to the Ministry of Health & Family Welfare to ₹1,06,530 crore, which is 10% increase from the previous year, and also announced five Regional Medical Hubs in collaboration with the private sector. In this blog, we will explore some healthcare companies in India that are delivering strong profitability to investors.
Why is healthcare stock built for every market cycle?
The Healthcare industry is one of the fastest-growing industries in India. India’s population of 1.4 billion is an ageing population. The Ayushman Bharat scheme, covering 50 Cr+ people and increasing healthcare awareness post the pandemic, is driving the increasing demand for quality healthcare services, and it is expected to increase every year.
The key advantage of healthcare stocks is the inelasticity of their services. Even in a recession, patients still need to go to hospitals, take medicines, and get surgeries. This defensive characteristic, along with high brand loyalty, growing networks, and increasing ARPOB (Average Revenue Per Occupied Bed), makes healthcare one of the best sectors for long-term compounding returns. The following are some of the most profitable stocks in India in the healthcare sector:
Apollo Hospitals
Apollo Hospitals is India’s largest hospital chain in terms of scale and revenue. Apollo Hospitals has a chain of 76 hospitals with over 10,400 operational beds. It reported a net profit of ₹502 crore in Q3FY26, which is a 35% YoY rise from the Rs 372 crore net profit reported in Q3 FY25.
To investors, Apollo Hospitals share price has delivered an ROCE of 15.53%, and it has delivered returns of around 135.77 % in the past five years, which makes it an attractive long-term compounder with a strong brand name, scale, and diversification across hospitals, pharmacies, and diagnostics.
Max Healthcare
Max Healthcare is primarily engaged in the provision of healthcare services through primary care clinics, super-speciality hospital facilities, and multi-speciality hospitals / medical centres. In its Q3FY26 results, Max Healthcare posted a net profit of ₹344 crore with a 9% year-on -year increase. It has the highest ARPOB (average revenue per occupied bed) at₹77,900 per day.
The company operates 20 healthcare facilities, mostly in North India, with 5,200 beds. Its network includes hospitals and clinics in Mohali, Bathinda, Dehradun, Gurgaon, Delhi NCR, Lucknow, Mumbai, Nagpur, Bulandshahr, etc. Max Healthcare has delivered returns of 342.34% in the last five years. Along with this, its stock has a ROCE of 11.47%.
Fortis Healthcare
Fortis Healthcare’s journey is being redefined by new owners, IHH Healthcare, with operational efficiency and growth, improving EBITDA margins, and high brand awareness across geographies. In its Q3FY26 results, it reported a gross profit of ₹3385 crore with a 38.78% Y-o-Y increase.
IHH Healthcare is further aiming to increase its stake in Fortis to 50%. Fortis Healthcare has returned 338.98% over the past five years, and it has a ROCE of 9.86%, which makes it an attractive long-term stock for investors.
Conclusion
The one thing that makes the healthcare sector in India different from other growth industries is that its structural, inelastic, and growing demand is independent of market conditions. The support from government policies, rising disposable incomes, growing insurance coverage, and an ageing population is driving long-term revenue visibility for healthcare companies.
Additionally, the growing ARPOB, margin improvement, and capacity addition further enhance their growth prospects for the next few years, making them attractive long-term stocks for investors.